The primary effectiveness endpoint was the proportion of patients who maintained pain control -LSB- change from baseline in mean pain intensity ( @-point numerical rating scale ) less than +@ for @ consecutive days and no more than two doses of rescue medication per day for @ consecutive days ) during the first week of open-label treatment .